In addition, in vitro‐generated DCs that were stimulated with TRIMEL from melanoma patients induced a fivefold increase in IFN‐γ release through a melanoma‐specific cytotoxic T cell clone, compared to APCs that were stimulated with a non‐HS‐treated melanoma cell lysate.[205, 206]. Here, IFNG is linked to melanoma.